PENUMBRA INC (PEN) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:PEN • US70975L1070

338.97 USD
-0.08 (-0.02%)
At close: Feb 10, 2026
339.365 USD
+0.39 (+0.12%)
After Hours: 2/10/2026, 4:15:00 PM
Fundamental Rating

6

Taking everything into account, PEN scores 6 out of 10 in our fundamental rating. PEN was compared to 186 industry peers in the Health Care Equipment & Supplies industry. PEN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PEN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, PEN could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year PEN was profitable.
  • PEN had a positive operating cash flow in the past year.
  • In multiple years PEN reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: PEN reported negative operating cash flow in multiple years.
PEN Yearly Net Income VS EBIT VS OCF VS FCFPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • With an excellent Return On Assets value of 9.40%, PEN belongs to the best of the industry, outperforming 91.94% of the companies in the same industry.
  • PEN's Return On Equity of 12.07% is amongst the best of the industry. PEN outperforms 88.71% of its industry peers.
  • With an excellent Return On Invested Capital value of 7.37%, PEN belongs to the best of the industry, outperforming 82.26% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for PEN is significantly below the industry average of 8.79%.
  • The last Return On Invested Capital (7.37%) for PEN is above the 3 year average (2.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.4%
ROE 12.07%
ROIC 7.37%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
PEN Yearly ROA, ROE, ROICPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

  • PEN has a Profit Margin of 12.30%. This is amongst the best in the industry. PEN outperforms 88.17% of its industry peers.
  • PEN's Profit Margin has declined in the last couple of years.
  • The Operating Margin of PEN (12.95%) is better than 80.65% of its industry peers.
  • PEN's Operating Margin has declined in the last couple of years.
  • The Gross Margin of PEN (66.80%) is better than 71.51% of its industry peers.
  • PEN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.95%
PM (TTM) 12.3%
GM 66.8%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
PEN Yearly Profit, Operating, Gross MarginsPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PEN is destroying value.
  • Compared to 1 year ago, PEN has less shares outstanding
  • Compared to 5 years ago, PEN has more shares outstanding
  • The debt/assets ratio for PEN has been reduced compared to a year ago.
PEN Yearly Shares OutstandingPEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
PEN Yearly Total Debt VS Total AssetsPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • PEN has an Altman-Z score of 22.57. This indicates that PEN is financially healthy and has little risk of bankruptcy at the moment.
  • PEN has a Altman-Z score of 22.57. This is amongst the best in the industry. PEN outperforms 96.77% of its industry peers.
  • PEN has a debt to FCF ratio of 0.15. This is a very positive value and a sign of high solvency as it would only need 0.15 years to pay back of all of its debts.
  • PEN has a better Debt to FCF ratio (0.15) than 93.01% of its industry peers.
  • PEN has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • PEN's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. PEN outperforms 72.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Altman-Z 22.57
ROIC/WACC0.75
WACC9.78%
PEN Yearly LT Debt VS Equity VS FCFPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • PEN has a Current Ratio of 6.73. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 6.73, PEN belongs to the best of the industry, outperforming 85.48% of the companies in the same industry.
  • PEN has a Quick Ratio of 4.18. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of PEN (4.18) is better than 76.88% of its industry peers.
Industry RankSector Rank
Current Ratio 6.73
Quick Ratio 4.18
PEN Yearly Current Assets VS Current LiabilitesPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

8

3. Growth

3.1 Past

  • PEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.47%, which is quite impressive.
  • Measured over the past years, PEN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.23% on average per year.
  • PEN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.61%.
  • Measured over the past years, PEN shows a quite strong growth in Revenue. The Revenue has been growing by 16.89% on average per year.
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%

3.2 Future

  • Based on estimates for the next years, PEN will show a very strong growth in Earnings Per Share. The EPS will grow by 24.42% on average per year.
  • PEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.24% yearly.
EPS Next Y33.22%
EPS Next 2Y33.5%
EPS Next 3Y31.53%
EPS Next 5Y24.42%
Revenue Next Year16.21%
Revenue Next 2Y15.29%
Revenue Next 3Y14.8%
Revenue Next 5Y13.24%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PEN Yearly Revenue VS EstimatesPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
PEN Yearly EPS VS EstimatesPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 93.38 indicates a quite expensive valuation of PEN.
  • Based on the Price/Earnings ratio, PEN is valued a bit cheaper than 66.67% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.06. PEN is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 66.27 indicates a quite expensive valuation of PEN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 67.20% of the companies listed in the same industry.
  • PEN is valuated expensively when we compare the Price/Forward Earnings ratio to 27.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 93.38
Fwd PE 66.27
PEN Price Earnings VS Forward Price EarningsPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 65.05% of the companies in the same industry are more expensive than PEN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, PEN is valued a bit cheaper than 70.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 86.97
EV/EBITDA 66.68
PEN Per share dataPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
  • PEN has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as PEN's earnings are expected to grow with 31.53% in the coming years.
PEG (NY)2.81
PEG (5Y)3.85
EPS Next 2Y33.5%
EPS Next 3Y31.53%

0

5. Dividend

5.1 Amount

  • PEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PENUMBRA INC

NYSE:PEN (2/10/2026, 4:15:00 PM)

After market: 339.365 +0.39 (+0.12%)

338.97

-0.08 (-0.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-24
Inst Owners97.98%
Inst Owner Change-0.07%
Ins Owners3.7%
Ins Owner Change0.91%
Market Cap13.27B
Revenue(TTM)1.33B
Net Income(TTM)164.03M
Analysts85.83
Price Target364.19 (7.44%)
Short Float %4.59%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.92%
Min EPS beat(2)3.63%
Max EPS beat(2)4.22%
EPS beat(4)4
Avg EPS beat(4)9.67%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)11.2%
EPS beat(12)12
Avg EPS beat(12)25.5%
EPS beat(16)14
Avg EPS beat(16)17.71%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.56%
Max Revenue beat(2)3.05%
Revenue beat(4)4
Avg Revenue beat(4)1.89%
Min Revenue beat(4)0.28%
Max Revenue beat(4)3.05%
Revenue beat(8)6
Avg Revenue beat(8)0.73%
Revenue beat(12)10
Avg Revenue beat(12)1.17%
Revenue beat(16)12
Avg Revenue beat(16)1.31%
PT rev (1m)7.63%
PT rev (3m)13.65%
EPS NQ rev (1m)1.57%
EPS NQ rev (3m)0.11%
EPS NY rev (1m)0.46%
EPS NY rev (3m)1.27%
Revenue NQ rev (1m)1.32%
Revenue NQ rev (3m)1.37%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 93.38
Fwd PE 66.27
P/S 9.95
P/FCF 86.97
P/OCF 65.3
P/B 9.77
P/tB 11.2
EV/EBITDA 66.68
EPS(TTM)3.63
EY1.07%
EPS(NY)5.12
Fwd EY1.51%
FCF(TTM)3.9
FCFY1.15%
OCF(TTM)5.19
OCFY1.53%
SpS34.06
BVpS34.7
TBVpS30.28
PEG (NY)2.81
PEG (5Y)3.85
Graham Number53.23
Profitability
Industry RankSector Rank
ROA 9.4%
ROE 12.07%
ROCE 10.97%
ROIC 7.37%
ROICexc 10.5%
ROICexgc 12.46%
OM 12.95%
PM (TTM) 12.3%
GM 66.8%
FCFM 11.44%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexgc growth 3Y49.31%
ROICexgc growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Debt/EBITDA 0.11
Cap/Depr 291.22%
Cap/Sales 3.8%
Interest Coverage 250
Cash Conversion 106.89%
Profit Quality 93.05%
Current Ratio 6.73
Quick Ratio 4.18
Altman-Z 22.57
F-Score7
WACC9.78%
ROIC/WACC0.75
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
EPS Next Y33.22%
EPS Next 2Y33.5%
EPS Next 3Y31.53%
EPS Next 5Y24.42%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
Revenue Next Year16.21%
Revenue Next 2Y15.29%
Revenue Next 3Y14.8%
Revenue Next 5Y13.24%
EBIT growth 1Y54.5%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year80.23%
EBIT Next 3Y41.84%
EBIT Next 5Y26.5%
FCF growth 1Y222.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y225.73%
OCF growth 3Y160.78%
OCF growth 5Y44.6%

PENUMBRA INC / PEN FAQ

What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to PEN.


What is the valuation status of PENUMBRA INC (PEN) stock?

ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.


Can you provide the profitability details for PENUMBRA INC?

PENUMBRA INC (PEN) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for PEN stock?

The Earnings per Share (EPS) of PENUMBRA INC (PEN) is expected to grow by 33.22% in the next year.